mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.05 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.06 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.063 |
0.06 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.06 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.06 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.06 |